Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-11-25FDA Approved: CLARITIN-D 12 HOUR — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin-D 12 Hour, combining loratadine and pseudoephedrine sulfate. The approval expands the p…
-
FDA approval · 2015-11-25FDA Approved: CLARITIN-D 24 HOUR — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application for Claritin-D 24 Hour (loratadine and pseudoephedrine sulfate) from Bayer HealthCare LLC.
-
FDA approval · 2015-11-25FDA Approved: CHILDRENS FLONASE ALLERGY RELIEF — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for Children's Flonase Allergy Relief (fluticasone propionate) from Haleon US Holdings LLC, expandin…
-
FDA approval · 2015-11-25FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer Healthcare LLC.)
FDA approved a supplemental application for Claritin RediTabs (loratadine) from Bayer Healthcare, likely related to a labeling or formulatio…
-
FDA approval · 2015-11-25FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer HealthCare LLC)
The FDA approved a supplemental application for Claritin RediTabs (loratadine) from Bayer HealthCare LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-11-25FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for Glenmark Pharmaceuticals' generic levocetirizine dihydrochloride.
-
FDA approval · 2015-11-24FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for levocetirizine dihydrochloride from Camber Pharmaceuticals, confirming its status as a generic a…
-
FDA approval · 2015-11-20FDA Approved: BUDESONIDE — Supplemental Application (Rite Aid Corporation)
FDA approved a supplemental application for Budesonide filed by Rite Aid Corporation (ANDA078949), confirming an updated approval for this g…
-
CLINICAL_TRIALS trial_result · 2015-11-11Clinical Trial Update: Tolerability of SLIT With LAIS® 2-Tree Allergoid Tablets
The trial update reports on the tolerability of SLIT with LAIS 2-Tree Allergoid Tablets in adults with allergic rhinitis, based on the compl…
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy [Phase 3]
Phase 3 trial evaluating house dust mite allergen extracts for sublingual immunotherapy in allergic rhinitis. Current status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: Evaluation of Efficacy and Safety of Specific Immunotherapy With Modified Allergen Extracts of House Dust Mites [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy and safety of modified house dust mite allergen extracts for specific immunotherapy in a…
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts [Phase 3]
A Phase 3 multicenter clinical trial is evaluating the safety and efficacy of specific immunotherapy using modified allergen extracts for al…
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: Efficacy and Safety of Sublingual Immunotherapy (SLIT) [Phase 3]
Phase 3 trial update evaluating the efficacy and safety of sublingual immunotherapy (SLIT) for allergic rhinitis. The current status of the …
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: Two Formulations and Concentrations of Epinastine Nasal Spray Versus Azelastine Nasal Solution for Allergic Rhinitis [Phase 2]
A Phase 2 clinical trial compared two epinastine nasal spray formulations with azelastine nasal solution for allergic rhinitis. The study st…
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis
A completed clinical trial assessed the effect of allergen immunotherapy on exhaled nitric oxide in adults with allergic asthma and allergic…
-
CLINICAL_TRIALS research · 2015-10-22Clinical Trial Update: Study Evaluating Nasal Symptoms Induced by a Nasal Allergen Challenge (NAC) To House Dust Mite Allergen
A completed clinical trial evaluating nasal symptoms induced by a nasal allergen challenge with house dust mite allergen.
-
FDA approval · 2015-10-21FDA Approved: CLARITIN ALLERGY — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin Allergy (loratadine) submitted by Bayer HealthCare LLC.
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children [Phase 3]
A multicenter Phase 3 trial evaluating sublingual grass pollen allergen extract for children with allergic rhinoconjunctivitis has completed…
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR) [Phase 3]
Phase 3 clinical trial in children aged 4 to 11 comparing an investigational nasal aerosol to placebo for perennial allergic rhinitis; trial…
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR) [Phase 3]
Phase 3 trial update on hypothalamic-pituitary-adrenal axis safety in pediatric perennial allergic rhinitis; the study is completed and resu…
-
CLINICAL_TRIALS trial_result · 2015-10-07Clinical Trial Update: The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel
This clinical trial update notes that the Ambrosia-related study in Israel addressing allergic rhinitis and asthma has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-01Clinical Trial Update: Comparison of the Effects of Nasal Steroids and Montelukast on Olfactory Functions in Patients With Allergic Rhinitis [Phase 4]
Phase 4 trial comparing nasal corticosteroids to montelukast to evaluate their effects on olfactory function in patients with allergic rhini…
-
FDA label_change · 2015-09-30FDA Approved: CHILDRENS FLONASE ALLERGY RELIEF — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Children's Flonase Allergy Relief (fluticasone propionate) from Haleon US Holdings LLC, upda…
-
FDA approval · 2015-09-24FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application for Claritin Chewable Grape and Bubblegum (loratadine) from Bayer HealthCare LLC, expanding the …
-
FDA label_change · 2015-09-24FDA Approved: ALLEGRA HIVES 24HR — Supplemental Application (Chattem, Inc.)
FDA supplemental application to update the labeling for Allegra Hives 24HR (fexofenadine hydrochloride) submitted by Chattem, Inc.